For others, the decision to use BPC-157 should involve careful consideration of the limited evidence base, potential risks from unregulated products, and consultation with knowledgeable healthcare providers.
Research on mitochondria in autism and methylation has revealed that many individuals on the spectrum share a pattern of low cellular energy, high oxidative stress, and difficulty maintaining biochemical balance
The gut microbiota plays a crucial role in constituting the intestinal barrier, enhancing the immune response of the intestinal mucosa, and maintaining the intestinal environment
not primarily appetite-driven (OUP Academic) Expected weight loss (this is where many people get misled) In major obesity trials: Semaglutide 2.4 mg weekly: ~14.9% mean weight loss at 68 weeks (STEP-1) (PubMed) Tirzepatide: ~15.0% to ~20.9% mean weight loss at 72 weeks , dose-dependent (SURMOUNT-1) (PubMed) AOD-9604s best-known human signal is kilograms, not double-digit percentages , and later studies did not sustain a strong obesity-drug profile
